X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5962) 5962
male (4389) 4389
female (4290) 4290
middle aged (3996) 3996
aged (3713) 3713
surgery (2698) 2698
adult (2604) 2604
bile duct neoplasms - surgery (1900) 1900
bile duct neoplasms - mortality (1728) 1728
retrospective studies (1677) 1677
aged, 80 and over (1650) 1650
gastroenterology & hepatology (1602) 1602
bile duct neoplasms - pathology (1595) 1595
prognosis (1563) 1563
cancer (1549) 1549
treatment outcome (1402) 1402
survival rate (1265) 1265
oncology (1209) 1209
cholangiocarcinoma (1205) 1205
cholangiocarcinoma - pathology (1143) 1143
cholangiocarcinoma - mortality (1129) 1129
cholangiocarcinoma - surgery (1117) 1117
medicine & public health (965) 965
carcinoma (960) 960
survival (901) 901
bile ducts, intrahepatic (893) 893
common bile duct neoplasms - surgery (843) 843
follow-up studies (830) 830
neoplasm staging (804) 804
risk factors (791) 791
mortality (786) 786
liver (765) 765
hepatectomy (735) 735
pancreaticoduodenectomy (719) 719
management (712) 712
tumors (711) 711
pancreatic neoplasms - surgery (698) 698
survival analysis (670) 670
resection (665) 665
analysis (645) 645
gastroenterology (611) 611
bile ducts, intrahepatic - pathology (610) 610
intrahepatic cholangiocarcinoma (601) 601
hilar cholangiocarcinoma (578) 578
time factors (555) 555
liver neoplasms - surgery (531) 531
bile duct neoplasms - diagnosis (527) 527
bile (518) 518
ampulla of vater (510) 510
common bile duct neoplasms - mortality (510) 510
stents (477) 477
bile duct neoplasms - therapy (467) 467
ampulla of vater - surgery (466) 466
common bile duct neoplasms - pathology (465) 465
hepatectomy - methods (459) 459
lymphatic metastasis (459) 459
palliative care (453) 453
kaplan-meier estimate (452) 452
adenocarcinoma - surgery (447) 447
chemotherapy (443) 443
health aspects (434) 434
bile ducts, intrahepatic - surgery (426) 426
hepatocellular-carcinoma (424) 424
abridged index medicus (409) 409
liver neoplasms - mortality (405) 405
metastasis (405) 405
diagnosis (387) 387
multivariate analysis (387) 387
pancreatic neoplasms - mortality (387) 387
liver neoplasms - pathology (381) 381
pathology (376) 376
adenocarcinoma - mortality (372) 372
neoplasm invasiveness (371) 371
drainage (367) 367
prospective studies (366) 366
cholangiocarcinoma - diagnosis (365) 365
gastroenterology and hepatology (364) 364
abdominal surgery (354) 354
bile duct neoplasms - complications (351) 351
immunohistochemistry (349) 349
cholangiocarcinoma - therapy (348) 348
experience (343) 343
liver cancer (342) 342
proportional hazards models (329) 329
animals (327) 327
disease-free survival (327) 327
postoperative complications (327) 327
bile duct neoplasms - metabolism (326) 326
patients (321) 321
adenocarcinoma (319) 319
ampulla of vater - pathology (319) 319
hepatology (310) 310
cholestasis - etiology (308) 308
surgical oncology (304) 304
complications (299) 299
research (298) 298
cholangiocarcinoma - metabolism (296) 296
pancreas (294) 294
care and treatment (292) 292
pancreatic cancer (292) 292
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5862) 5862
German (192) 192
French (67) 67
Japanese (60) 60
Italian (59) 59
Chinese (46) 46
Spanish (44) 44
Russian (40) 40
Portuguese (14) 14
Korean (13) 13
Bulgarian (9) 9
Danish (7) 7
Dutch (7) 7
Polish (6) 6
Romanian (6) 6
Czech (5) 5
Norwegian (5) 5
Bosnian (2) 2
Hungarian (2) 2
Serbian (2) 2
Hebrew (1) 1
Lithuanian (1) 1
Swedish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Oncotarget, ISSN 1949-2553, 2014, Volume 5, Issue 9, pp. 2839 - 2852
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2016, Volume 22, Issue 4, pp. 676 - 681
...) of grades II to IV was 47%, and that of chronic GVHD was 32%. Treatment-related mortality was 21%. At 5... 
Hematology, Oncology and Palliative Medicine | Pancreatic adenocarcinoma | Allogeneic hematopoietic stem cell transplantation | Colon carcinoma | Renal carcinoma | Cholangiocarcinoma | DONOR | BONE-MARROW | GRAFT | IMMUNOLOGY | VERSUS-HOST-DISEASE | TRANSPLANTATION | BREAST-CANCER | PRIMARY LIVER-CANCER | LEUKEMIA | HEMATOLOGY | COLON-CARCINOMA | MARROW TRANSPLANTATION | BLOOD | Adenocarcinoma - pathology | Follow-Up Studies | Breast Neoplasms - immunology | Humans | Middle Aged | Kidney Neoplasms - immunology | Male | Graft vs Host Disease - immunology | Cyclophosphamide - therapeutic use | Transplantation, Homologous | Prostatic Neoplasms - immunology | Prostatic Neoplasms - therapy | Breast Neoplasms - therapy | Bile Duct Neoplasms - immunology | Neoplasm Metastasis | Graft vs Host Disease - mortality | Colonic Neoplasms - immunology | Adult | Female | Pancreatic Neoplasms - mortality | Transplantation Conditioning - methods | Graft vs Host Disease - diagnosis | Kidney Neoplasms - therapy | Colonic Neoplasms - therapy | Prostatic Neoplasms - pathology | Colonic Neoplasms - mortality | Adenocarcinoma - immunology | Pancreatic Neoplasms - pathology | Hematopoietic Stem Cell Transplantation | Vidarabine - analogs & derivatives | Vidarabine - therapeutic use | Kidney Neoplasms - mortality | Myeloablative Agonists | Prostatic Neoplasms - mortality | Graft vs Host Disease - pathology | Bile Duct Neoplasms - therapy | Adenocarcinoma - therapy | Breast Neoplasms - pathology | Bile Duct Neoplasms - mortality | Colonic Neoplasms - pathology | Pancreatic Neoplasms - immunology | Survival Analysis | Breast Neoplasms - mortality | Kidney Neoplasms - pathology | Aged | Bile Duct Neoplasms - pathology | Adenocarcinoma - mortality | Pancreatic Neoplasms - therapy | Liver cancer | Colon cancer | Pancreatic cancer | Liver | Mortality | Stem cells | Transplantation | Metastasis | Health aspects | Prostate cancer | Risk factors | Hematopoietic stem cells | College teachers
Journal Article
Journal of the American College of Surgeons, ISSN 1072-7515, 2016, Volume 224, Issue 4, pp. 406 - 413
Journal Article
Journal Article
Journal Article
World journal of gastroenterology : WJG, ISSN 1007-9327, 12/2013, Volume 19, Issue 46, pp. 8595 - 8604
Journal Article
Journal Article
Annals of surgical oncology, ISSN 1534-4681, 2018, Volume 25, Issue 9, pp. 2652 - 2660
Journal Article
Journal Article
Annals of surgical oncology, ISSN 1534-4681, 2010, Volume 18, Issue 3, pp. 651 - 658
Journal Article
Modern pathology, ISSN 1530-0285, 2013, Volume 27, Issue 1, pp. 73 - 86
Intraductal papillary neoplasms of the bile duct are still poorly characterized regarding (1... 
GNAS | bile duct tumors | KRAS | intraductal precursor lesion | CHOLANGIOCARCINOMA | TRACT CANCERS | PANCREAS | PATHOLOGY | GNAS MUTATIONS | BILIARY INTRAEPITHELIAL NEOPLASIA | GROWTH-FACTOR RECEPTOR | IMMUNOHISTOCHEMICAL ANALYSIS | MUCINOUS NEOPLASM | EXPRESSION | CLINICOPATHOLOGICAL FEATURES | Immunohistochemistry | Bile Ducts, Intrahepatic - chemistry | ras Proteins - genetics | Carcinoma in Situ - chemistry | Proto-Oncogene Proteins p21(ras) | Prognosis | Humans | Middle Aged | Male | Carcinoma, Intraductal, Noninfiltrating - genetics | Carcinoma, Intraductal, Noninfiltrating - mortality | Papilloma - chemistry | Tumor Suppressor Protein p53 - analysis | Carcinoma in Situ - genetics | Cyclin-Dependent Kinase Inhibitor p16 - analysis | Neoplasm Grading | Time Factors | DNA Mutational Analysis | Bile Duct Neoplasms - chemistry | Aged, 80 and over | Adult | Female | Papilloma - pathology | Bile Duct Neoplasms - genetics | Papilloma - genetics | Bile Ducts, Intrahepatic - pathology | Signal Transduction | Biomarkers, Tumor - analysis | Carcinoma in Situ - pathology | Neoplasm Invasiveness | Europe | Kaplan-Meier Estimate | Proportional Hazards Models | Proto-Oncogene Proteins - genetics | Papilloma - mortality | Carcinoma, Intraductal, Noninfiltrating - chemistry | Disease Progression | Cholangiocarcinoma - pathology | Carcinoma, Intraductal, Noninfiltrating - pathology | Biopsy | Cholangiocarcinoma - chemistry | Bile Duct Neoplasms - mortality | Cholangiocarcinoma - genetics | Aged | Biomarkers, Tumor - genetics | Bile Duct Neoplasms - pathology | Mutation | Carcinoma in Situ - mortality
Journal Article
Journal Article